Drs. Nancy Kuntz and Laurent Servais report on exciting developments related to Duchenne Muscular Dystrophy shared at a recent international neuromuscular conference. Data from clinical trials in gene therapy for Duchenne show promising results after 4 years post-dosing. Find out more about the longevity of gene therapy for these patients.